Mevastatin

73573-88-3

C23H34O5

DMSO : 25 mg/mL (64.02 mM; Need ultrasonic)

Autophagy; Metabolic Enzyme/Protease

Mevastatin (Compactin; ML236B) inhibits HMGCR (HMG-CoA reductase) (Ki for acid form is 1 nM) which in turn inhibits isoprenoid biosynthesis and therefore blocks protein isoprenylation and reduces plasma cholesterol levels in humans. IC50 value: 1 nM (Ki) Target: HMGCR Mevastatin induces apoptosis, arrests cancer cells in G1 phase and downregulates cdk 2, 4, and 6, cyclin D1 and E1, p21 and p27. Mevastatin suppresses TNF-induced NF-kappaB activation (IC50 = ca.17 uM), which potentiates apoptosis in human myeloid leukemia cells and thus, may be useful in treating cancer.